Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B K Tang

Showing results (61-70 of 68) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 68 results.
Annals of Internal Medicine|August 1, 1986
Differences in metabolism of sulfonamides predisposing to idiosyncratic toxicityN H Shear, S P Spielberg, D M Grant, et al.
American Journal of Therapeutics|January 1, 1995
Individual Variability of Carbonyl Reductase Activity for Acetohexaminde in Human ErythorcytesM. Kishimoto, H. Sano, F. Chang, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|January 8, 1999
Trimethadione metabolism by human liver cytochrome P450: evidence for the involvement of CYP2E1N Kurata, Y Nishimura, M Iwase, et al.
Pharmacogenetics|August 1, 1996
Role of CYP1A2 in caffeine pharmacokinetics and metabolism: studies using mice deficient in CYP1A2J T Buters, B K Tang, T Pineau, et al.
Occupational and Environmental Medicine|February 1, 1995
Induction of P-450 in workers exposed to dioxinW Halperin, W Kalow, M H Sweeney, et al.
Pharmacogenetics|July 18, 2000
Evaluation of the genetic component of variability in CYP3A4 activity: a repeated drug administration methodV Ozdemir, W Kalow, B K Tang, et al.
Journal of Clinical Psychopharmacology|July 31, 2001
CYP1A2 activity as measured by a caffeine test predicts clozapine and active metabolite steady-state concentrationin patients with schizophreniaV Ozdemir, W Kalow, P Posner, et al.
British Journal of Clinical Pharmacology|October 9, 1998
Caffeine based measures of CYP1A2 activity correlate with oral clearance of tacrine in patients with Alzheimer's diseaseR J Fontana, T M deVries, T F Woolf, et al.
Pageof 7

Showing results (61-70 of 68) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
Annals of Internal Medicine|August 1, 1986
Differences in metabolism of sulfonamides predisposing to idiosyncratic toxicityN H Shear, S P Spielberg, D M Grant, et al.
American Journal of Therapeutics|January 1, 1995
Individual Variability of Carbonyl Reductase Activity for Acetohexaminde in Human ErythorcytesM. Kishimoto, H. Sano, F. Chang, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|January 8, 1999
Trimethadione metabolism by human liver cytochrome P450: evidence for the involvement of CYP2E1N Kurata, Y Nishimura, M Iwase, et al.
Pharmacogenetics|August 1, 1996
Role of CYP1A2 in caffeine pharmacokinetics and metabolism: studies using mice deficient in CYP1A2J T Buters, B K Tang, T Pineau, et al.
Occupational and Environmental Medicine|February 1, 1995
Induction of P-450 in workers exposed to dioxinW Halperin, W Kalow, M H Sweeney, et al.
Pharmacogenetics|July 18, 2000
Evaluation of the genetic component of variability in CYP3A4 activity: a repeated drug administration methodV Ozdemir, W Kalow, B K Tang, et al.
Journal of Clinical Psychopharmacology|July 31, 2001
CYP1A2 activity as measured by a caffeine test predicts clozapine and active metabolite steady-state concentrationin patients with schizophreniaV Ozdemir, W Kalow, P Posner, et al.
British Journal of Clinical Pharmacology|October 9, 1998
Caffeine based measures of CYP1A2 activity correlate with oral clearance of tacrine in patients with Alzheimer's diseaseR J Fontana, T M deVries, T F Woolf, et al.
Pageof 7